Nyrada (ASX:NYR) ROE % Adjusted to Book Value : 8.11% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nyrada ROE % Adjusted to Book Value?

Nyrada's ROE % for the quarter that ended in Dec. 2023 was 6.16%. Nyrada's PB Ratio for the quarter that ended in Dec. 2023 was 0.76. Nyrada's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 8.11%.

Nyrada ROE % Adjusted to Book Value Historical Data

The historical data trend for Nyrada's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyrada ROE % Adjusted to Book Value Chart

Nyrada Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

-25.65

-10.28

-16.74

-94.98

Nyrada Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-13.62	-10.73	-20.95	-146.26	8.11

Competitive Comparison of Nyrada's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Nyrada's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nyrada's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nyrada's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Nyrada's ROE % Adjusted to Book Value falls into.

Nyrada ROE % Adjusted to Book Value Calculation

Nyrada's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-98.78%	/	1.04
	=	-94.98%

Nyrada's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	6.16%	/	0.76
	=	8.11%

Nyrada ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Nyrada's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyrada (ASX:NYR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nyrada Inc (ASX:NYR) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

828 Pacific Highway, Suite 2, Level 3, Gordon, NSW, AUS, 2072

Website

https://www.nyrada.com

Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

Nyrada (ASX:NYR) Headlines

No Headlines